We are live on ! Find out more
KFC

Klingenstein Fields & Co Portfolio holdings

AUM $2.86B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
+3.3%
1 Year Est. Return
+28.26%
3 Year Est. Return
+93.38%
5 Year Est. Return
+106.8%
10 Year Est. Return
+364.29%
AUM
$2.14B
AUM Growth
+$140M
Cap. Flow
+$83.4M
Cap. Flow %
3.9%
Top 10 Hldgs %
40.56%
Holding
223
New
11
Increased
84
Reduced
50
Closed
12
Avg Time Held
10.1 quarters
Top 10 Avg Time Held
7.6 quarters
Top 20 Avg Time Held
8.2 quarters

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$21.5M
2
MRK icon
Merck
MRK
+$15.8M
3
WY icon
Weyerhaeuser
WY
+$15M
4
AVGO icon
Broadcom
AVGO
+$12.9M
5
FDX icon
FedEx
FDX
+$6.19M

Sector Composition

Rank Sector Weight
1 Industrials 19.18%
2 Communication Services 17.11%
3 Healthcare 16.21%
4 Financials 14.28%
5 Consumer Staples 12.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DIS icon
1
Walt Disney
DIS
$187B
$194M 9.08%
1,986,272
+37,140
+2% +$3.71M
2013 Q2
12 quarters
PEP icon
2
PepsiCo
PEP
$173B
$142M 6.62%
1,337,762
+26,143
+2% +$2.7M
2013 Q2
12 quarters
BRK.B icon
3
Berkshire Hathaway Class B
BRK.B
$1.11T
$137M 6.41%
947,024
+11,909
+1% +$1.7M
2013 Q2
12 quarters
JNJ icon
4
Johnson & Johnson
JNJ
$636B
$91.2M 4.26%
751,757
+13,726
+2% +$1.56M
2013 Q2
12 quarters
UNP icon
5
Union Pacific
UNP
$167B
$54.1M 2.53%
619,822
+18,288
+3% +$1.55M
2013 Q2
12 quarters
CMCSA icon
6
Comcast
CMCSA
$73.4B
$54.1M 2.53%
1,658,292
+39,968
+2% +$1.24M
2013 Q2
12 quarters
GE icon
7
GE Aerospace
GE
$320B
$53.9M 2.52%
357,524
+7,994
+2% +$1.17M
2013 Q2
12 quarters
PG icon
8
Procter & Gamble
PG
$356B
$53.9M 2.52%
636,971
+6,429
+1% +$528K
2013 Q2
12 quarters
MMM icon
9
3M
MMM
$83B
$46.3M 2.17%
316,492
+6,308
+2% +$889K
2013 Q2
12 quarters
HON icon
10
Honeywell
HON
$66.4B
$41.2M 1.92%
393,798
+9,347
+2% +$961K
2013 Q2
12 quarters
RDS.A
11
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$39.2M 1.83%
748,477
+58,804
+9% +$2.84M
2013 Q2
12 quarters
CL icon
12
Colgate-Palmolive
CL
$71.7B
$37.4M 1.75%
510,758
+14,045
+3% +$1M
2013 Q2
12 quarters
HES icon
13
DELISTED
Hess
HES
$35.7M 1.67%
594,519
+29,984
+5% +$1.74M
2013 Q2
12 quarters
RTN
14
DELISTED
Raytheon Company
RTN
$34.3M 1.6%
251,934
+6,298
+3% +$820K
2013 Q2
12 quarters
MDT icon
15
Medtronic
MDT
$118B
$33.4M 1.56%
384,882
+7,805
+2% +$631K
2013 Q2
12 quarters
SLB icon
16
SLB Ltd
SLB
$72.4B
$31.8M 1.49%
402,333
+12,022
+3% +$922K
2013 Q2
12 quarters
RTX icon
17
RTX Corp
RTX
$252B
$31.3M 1.46%
484,396
+16,308
+3% +$1.04M
2013 Q2
12 quarters
AMT icon
18
American Tower
AMT
$85.1B
$30.7M 1.44%
270,631
+1,093
+0.4% +$116K
2013 Q2
12 quarters
TWX
19
DELISTED
Time Warner Inc
TWX
$29.1M 1.36%
395,527
+12,344
+3% +$913K
2014 Q2
8 quarters
FDX icon
20
FedEx
FDX
$69.2B
$29.1M 1.36%
191,566
+38,142
+25% +$6.19M
2013 Q2
12 quarters
LH icon
21
Labcorp
LH
$25.6B
$27M 1.26%
241,650
+13,800
+6% +$1.49M
2013 Q2
12 quarters
CVS icon
22
CVS Health
CVS
$112B
$26M 1.22%
271,910
+215,661
+383% +$21.5M
2013 Q2
12 quarters
LLY icon
23
Eli Lilly
LLY
$1.05T
$25.2M 1.18%
320,441
+11,030
+4% +$830K
2013 Q2
12 quarters
HIG icon
24
Hartford Financial Services
HIG
$35.3B
$24.5M 1.14%
551,788
+15,980
+3% +$713K
2013 Q2
12 quarters
NEM icon
25
Newmont
NEM
$123B
$24.4M 1.14%
624,640
+26,270
+4% +$870K
2013 Q2
12 quarters

Similar funds

Klingenstein Fields & Co's Q2 2016 Portfolio in Review

As of Q2 2016, Klingenstein Fields & Co held 223 positions worth $2.14B, up 7% from $2B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Klingenstein Fields & Co deployed $83.4M of net new capital in Q2 2016, opening 11 new positions and adding to 84 existing holdings. Its largest new stake was Broadcom: 845,850 shares worth $13.1M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 20% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $20M trimmed.

  • Klingenstein Fields & Co's largest Q2 2016 buy was Broadcom: 845,850 shares worth $13.1M.
  • Klingenstein Fields & Co added most to CVS Health in Q2 2016, an estimated $21.5M increase.
  • Klingenstein Fields & Co's biggest Q2 2016 reduction was AbbVie, cutting an estimated $20M.
  • Klingenstein Fields & Co fully exited ABB Ltd in Q2 2016, selling an estimated $13.9M.
  • Klingenstein Fields & Co's ten largest holdings make up 41% of its $2.14B portfolio in Q2 2016.
  • Klingenstein Fields & Co opened 11 new positions and closed 12 in Q2 2016.
  • Klingenstein Fields & Co's portfolio value rose 7% quarter-over-quarter to $2.14B.

Based on Klingenstein Fields & Co's 13F filing for Q2 2016, filed 1 Aug 2016.